Moonwalk Biosciences, a genomic medicine company pioneering precision epigenetic medicines, today announced the completion of $57 million in seed and Series A financing from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, GV, Khosla Ventures and YK Bioventures.
January 4, 2024
· 6 min read